Dr. Steven Dasong Wang has been a Director since April 2020. Dr. Wang has over 20 years of experience in working in global investment banks and direct investment firms. He is a partner and senior management director of Asia at OrbiMed Advisors LLC, an investment fund with a focus on the healthcare industry.
Prior to joining OrbiMed, he served as a managing director and head of APAC Healthcare Investment Banking at Credit Suisse (Hong Kong) Limited. He also held senior level roles in the investment banking departments in Hong Kong of UBS AG and Morgan Stanley. Dr. Wang obtained his Bachelor of Arts degree in chemistry from the University of Southern Maine in the U.S. and his Ph.D. degree in medicinal chemistry from the Johns Hopkins University in the U.S.. He also holds a Master of Business Administration degree (with distinction) from New York University. Dr. Wang is a Chartered Financial Analyst with the Association for Investment Management and Research. He is also currently a member of the board of directors for Union Medical Healthcare Limited, a company listed on the Hong Kong Stock Exchange (stock code: 2138).